fig2

Circulating tumor DNA (ctDNA) in early-stage NSCLC: a new frontier in precision oncology

Figure 2. Potential clinical applications of ctDNA across perioperative management. ctDNA: Circulating tumor DNA; MPR: major pathologic response; pCR: pathologic complete response. Created with BioRender.com (Created in BioRender. Cammarota, A. (2026) https://BioRender.com/aeszxg6).

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/